Rare cancer: “historic” breakthrough in Maisonneuve-Rosemont
Researchers from the Maisonneuve-Rosemont Hospital (HMR) have developed a new experimental cell therapy to tackle synovial sarcoma, a rare cancer that mainly affects young adults … Read more
